Bones and connective tissues Flashcards
synovial joint motions
gliding/linear; angular (may be abduction, adduction, flexion, extension, or circumduction); rotation
synovial joint types
gliding (surfaces slide across each other), hinge (movement in single plane), pivot (rotation between apposing parts), saddle, ellipsoid/condyloid (knuckle-like; oval face apposes a depression), ball-and-socket; all possess a cavity between the bones comprising the joint; apposing surfaces of each bone are covered by articular cartilage; joint is surrounded by a fibrous capsule that is lined internally with a synovial membrane that secretes lubricative fluid
concentric contraction
a type of isotonic contraction; occurs when the muscle shortens
eccentric contraction
a type of isotonic contraction; occurs when the muscle lengthens while contracting; involves a controlled but gradual relaxation that generates diminishing force or tension
isotonic contraction
when a skeletal muscle changes length as it generates force
isometric contraction
when a skeletal muscle creates tension or force without movement or change in length
muscle tone
slight amount of contraction that a muscle maintains even when relaxed in a conscious individual; lost when an individual is unconscious or has a nerve lesion causing paralysis
prime mover/agonist
the muscle or muscle group primarily responsible for the initiation and execution of a specific action at a joint; may be gravity
antagonist
muscle or muscle group that opposes or reverses the action of a prime mover; may act to stabilize the movement of the agonist
synergist
muscle or muscle group that assists the prime mover in its action(s); may provide additional pull at the origin, reduce some undesirable movements that the prime mover incidentally induces, hold a bone in place so that the prime mover has a stable base, or produce force simultaneously in a different direction to produce a rotation
fixator/stabilizer
a type of synergist that holds a bone in place so that the prime mover has a stable base
electromyography
Analysis of motor unit action potentials (MUAPs) and baseline electrical signal at rest in order to assess the health of a muscle and its innervating nerve
hyaline cartilage
most common type of cartilage; contains round or oval chondrocytes surrounded by pericellular matrix; usually surrounded by perichondrium; forms nasal, costal, laryngeal, bronchial, and articular cartilage; serves as a template for endochondral ossification; also present in epiphyseal plate cartilage
elastic cartilage
yellowish when fresh due to presence of elastin; usually surrounded by perichondrium; forms auricular, auditory, laryngeal, and epiglottal cartilage
articular cartilage
a specialized type of hyaline cartilage that has no perichondrium and covers the articulating surfaces of opposing bones in a joint; arranged in three zones - most superficial has collagen fibers arranged parallel to the surface, middle has fibers arranged obliquely, and deepest has fiber arranged perpendicular to the surface with mineralized cartilage matrix; thick band of mineralized matrix (tidemark) separates mineralized zone from more superficial zones
fibrocartilage
white and opaque due to predominance of type I collagen; contains bundles of collagen with chondrocytes arranged in a linear fashion parallel to collagen bundles; has no perichondrium; forms intervertebral disks, symphases, tendon insertions, and articular disks; also forms calluses during healing of a bone fracture
chondrocyte
cells found in cartilage that are embedded within the cartilage matrix; round, have basophilic cytoplasm, found in clusters called isogenous groups/cell nests; can divide, but less frequently as they age; produce components of cartilage matrix and enzymes that degrade cartilage matrix
aggrecan
predominant proteoglycan monomer found in cartilage ground substance; generally bound to a central hyaluronate backbone to form multi molecular proteoglycan aggregates
lacunae
cavities between concentric lamellae of bone osteons where osteocytes reside; also used to describe spaces in cartilage matrix where chondrocytes reside
perichondrium
outer layer of cartilage elements that encloses the cartilaginous structures; outer part is made of fibrous connective tissue (type I cartilage) secreted by fibroblasts and contains a capillary plexus, nerves, and lymphatics; inner part is made of chondrogenic cells that may become chondroblasts
cartilage-specific collagens
fibers that make up the fibrous component of cartilage matrix; give mechanical stability to the ground substance; type II collagen is predominant isoform; also includes types IX, X, and XI
appositional growth
type of cartilage growth in which it grows from within; caused by division of chondrocytes followed by separation due to matrix production; important for growth of long bones; generally occurs in young cartilage
interstitial growth
type of cartilage growth in which it grows from the surface; caused by chondrogenic cells inside the perichondrium differentiating into chondroblasts that express SOX 9, which subsequently secrete cartilage matrix and become enclosed within in
territorial matrix
cartilage matrix found in hyaline cartilage immediately surrounding chondrocytes; contains thin collagen fibers
interterritorial matrix
cartilage matrix found in hyaline cartilage in spaces between chondrocytes; contains thick collagen fibers and most of the proteoglycan
proteoglycan
contribute to the organic component of bone, along with collagen I and glycoproteins, though they exist in higher amounts in cartilage
glycosaminoglycan
macromolecular component of cartilage matrix; proteoglycans attached to core proteins, which are in turn attached to a hyaluronate backbone
hydroxyapatite
crystalized calcium phosphate that makes up the inorganic component of bone; forms alongside collagen I fibrils; primary mediator of the hardness of bone
osteoid
organic bone matrix; makes up 30% of total bone matrix; consists of type I collagen, proteoglycans, and glycoproteins secreted by osteoblasts; mediates calcification of bone
woven bone
AKA primary bone; weak, immature bone that is less organized than secondary bone; seen in developing or regenerating bone; during development, is resorbed and remodeled to produce secondary bone
compact bone
areas of bone that are dense and have no cavities; makes up cortical bone, in which 80-90% of volume is calcified; fulfills primarily a mechanical and protective function
trabecular bone
AKA spongy or cancellous bone; areas of bone that are highly trabeculated and caveated; 15-25% of volume is calcified, fulfills mainly a metabolic function (calcium reservoir); only makes up 20% of total bone volume but accounts for 80% of bone turnover/remodeling due to higher SA:volume ratio
lamellar bone
bone that is made up of osteons organized from concentric lamellae
canaliculi
tiny canals within bone osteons that connect lacunae in adjacent lamellae and contain osteocyte dendrites
osteocyte
differentiated osteoblasts; occupy lacunae that lie between lamellae of the bone matrix; function as endocrine cells and mechanosensor cells to regulate bone remodeling; communicate with neighboring cells via dendrites and gap junctions; express dental matrix protein 1 (DMP1) and sclerostin (SOST)
osteoblast
activated osteoprogenitor cells, located primarily in the inner layer of the periosteum (but some in the endosteum); mediate appositional growth of bone; differentiate under the influence of bone morphogenic proteins (BMPs), and are differentiated from other fibroblasts by the presence of Runx2 (bone master gene transcription factor) and osteocalcin; differentiate under the influence of Wnt/Beta-catenin signaling and RUNX2; primary protein product is type I collagen; also secrete osteoprogegerin (inhibits osteoclast differentiation) and SIBLING family proteins (modulators of mineralization)
osteoclast
large multinuclear cells that originate in the bone marrow and differentiate from the monocyte/macrophage lineage based on combinatorial signaling (M-CSF, RANKL, CTR, TRAP); occupy Howship’s lacunae on the endosteal surface of bone; activated by PTH and 1,25-OH-D and inhibited by calcitonin; destroy bone matrix and facilitate remodeling via secretion of protons (acid) and cathepsin-K
ruffled border
specialized cellular membrane that osteoclasts use to attach to bone matrix and create a microenvironment in which to resorb bone
Haversian canal
central canal in bone osteon surrounded by concentric lamella; transmits blood vessels, nerves, and lymphatics
Volkmann canal
canals in bone osteons that are continuous with the Haversian canal and connect adjacent lamellae; transmits blood vessels, nerves, and lymphatics
intramembranous ossification
primary method by which flat bones ossify; bone forms from ossification centers, where mesenchymal stem cells condense and differentiate into osteoblasts within reticular connective tissue, which allows deposition of bone matrix and ultimate incorporation of osteocytes into lacunae; process by which fontanelles in neonates are ossified
endochondral ossification
primary method by which long bones ossify; osteoblasts deposit bone on pre-existing hyaline cartilage template; begins with a primary ossification center in the diaphysis that leads to intramembranous ossification around the perichondrium; cartilage cells then hypertrophy; this allows osteoblasts to produce bone on calcified cartilage with concomitant cavitation; cycle repeats at epiphyses, where some hyaline cartilage is retained, both as articular cartilage and epiphyseal plate cartilage
epiphyseal plate
layer of hyaline cartilage found at the epiphyses of long bones
reserve zone
part of the epiphyseal plate; does not participate in bone growth; resident chondrocytes connect the epiphyseal plate to the osseous tissue of the epiphysis
proliferative zone
one of the zones of epiphyseal activation in the epiphyseal plate; sustained by IGF-1; makes cartilage matrix (type II collagen)
hypertrophy zone
one of the zones of epiphyseal activation in the epiphyseal plate; zone where chondrocytes enter apoptotic phase; susceptible for fractures, and is responsible for 20% of fractures in children
calcification zone
one of the zones of epiphyseal activation in the epiphyseal plate; chondrocyte proliferation is inhibited, type X collagen is synthesized, and hydroxyapatite formation begins; strongly basophilic
bone remodeling
bone synthesis and removal; occurs throughout the lifespan
bony callus
structure synthesized by osteoblasts during repair of bone fractures; replaces the fibrocartilaginous callus previously laid down by fibroblasts and chondroblasts, ultimately replaced by mature bone as it heals
mesenchymal stem cells
stem cells that may differentiate into osteoblasts or chondroblasts; population declines with age
osteoarthritis
family of degenerative joint diseases; characterized by progressive loss of articular cartilage; symptoms include chronic pain, joint deformity, and eventual disabilty
rheumatoid arthritis
disease caused by an inflammatory reaction against the synovium of joints; may lead to destruction of the joint; mediated by cytokines (i.e. IL-1, TNF-alpha) that stimulate release of proteases from chondrocytes and inflammatory cells, resulting in degradation of core proteins in proteoglycan aggregates
osteisis fibrosa cystia
a condition in which osteoclasts destroy bone matrix as it is made
Paget’s disease
a condition that affects adults over 40 y.o. in which abnormal osteoclasts cause a high rate of remodeling, resulting in an over-abundance of primary/woven bone; can cause pain, nerve entrapment, and weakening of affected areas; remodeling regulation disease
osteoporosis
condition characterized by hollow, fragile bones due to osteoclast-mediated resorption that occurs faster than osteogenesis; for every 10% loss in bone mass, the risk of fracture doubles
osteopetrosis
condition characterized by growth of dense, heavy bone that lacks lamellar structure (woven bone) due to immature osteoclasts that lack a ruffled membrane; may cause obliteration of bone marrow cavity and subsequent bone marrow suppression
anti-resorptive drugs
class of drugs used in the treatment of osteoporosis that prevent bone resorption/osteoclast differentiation; various classes include SERMs, bisphosphonates, and denosumab (binds RANKL)
anabolic drugs
class of drugs used in the treatment of osteoporosis that induces osteoblast differentiation; only FDA-approved drug in this class is teriparatide, or PTH 1-34; mimics PTH activity, such that daily spikes (due to daily administration) promote osteoblast induction
BMP-2/BMP-7
growth factors that induce stem cells in bone marrow to differentiate into osteoblasts; clinical trials have used recombinant BMPs to assist bone regeneration in patients
bisphosphonates
class of anti-resorptive drugs used in the treatment of osteoporosis; examples include alendronate, risedronate, ibandronate
SERMs
selective estrogen receptor modulators; class of anti-resorptive drugs used in the treatment of osteoporosis; example includes raloxifene
osteoprotegerin
protein secreted by PTH-stimulated MSCs and osteoblasts that inhibits osteoclast development by binding RANKL
RANKL
cell surface receptor expressed by PTH-stimulated MSCs that induces osteoclast development
M-CSF
cytokine that induces monocyte/macrophage proliferation and contributes to osteoclast development
leptin
hormone made by fat cells; induces the CNS to inhibit bone formation
IGF I
insulin-like growth factor 1; synthesized by the liver in response to somatotropin signaling
collagen I
part of the organic component of bone, along with proteoglycans and glycoproteins; arranged in an anti-helical fashion that helps mediate the hardness of bones
collagen X
synthesized by chondrocytes in the calcification zone of the epiphyseal plate; facilitates beginning of hydroxyapatite formation, later replaced by collagen I from osteoblasts
cathepsin-K
lysosomal enzyme secreted by osteoclasts that is activated by a low pH and facilitates breakdown of bone matrix during remodeling
parathyroid hormone
hormone secreted by the parathyroid that stimulates osteoclasts to facilitate bone resorption and calcium release
calcitonin
hormone that inhibits osteoclasts to prevent bone resorption
osteocalcin
glycoprotein that is specific to bone and promotes its mineralization
estrogen
sex hormone that stimulates somatotropin release from the pituitary gland; estradiol also decreases chondrocyte GAG synthesis
testosterone
sex hormone that stimulates somatotropin release from the pituitary gland; also induces chondrocyte GAG synthesis
somatotropin
AKA growth hormone; secreted by the pituitary gland in response to estrogen and/or testosterone stimulation; induces the liver to make insulin-like growth factor 1 (IGF-1); also induces chondrocyte GAG synthesis
glycoproteins
contribute to the organic component of bone, along with collagen I and proteoglycans; includes glycosylated proteins that promote calcification, esp. osteocalcin
noncollagenous multiadhesive glycoproteins
components of cartilage matrix; consist of small regulatory and structural proteins that influence interaction between chondrocytes and the ECM; examples include chondronectin, tenascin, and anchorin CII; clinically valuable as markers of cartilage turnover and degradation
Heinemann size principle
in a given movement/muscle contraction, the smallest motor units fire first, followed by recruitment of larger motor units as the firing frequency of the first units increases to a particular threshold
uricosuric
drug that increases the rate of excretion of uric acid; class of drugs commonly used in the treatment of gout
disease-modifying anti-rheumatic drugs (DMARDs)
class of drugs used in treatment of RA that slow down or stop joint damage; generally biological response modifiers/biologics
allopurinol
used in the treatment of gout; structural analog of hypoxanthine, converted to oxypurinol by aldehyde oxidoreductase, inhibits terminal steps in uric acid biosynthesis by blocking xanthine oxidase; oxypurinol has very long half-life; side effects include hypersensitivity rxns, acute gout attacks (decreased plasma uric acid levels mobilizes tissue stores of uric acid - generally co-administered with colchicine or NSAID); inhibits metabolism of azathioprine and mercaptopurine
adalimumab
IgG mAb used in the treatment of RA and juvenile idiopathic arthritis; anti-TNF-alpha, binds both soluble and transmembrane forms to prevent it from binding its receptor (binding transmembrane forms may also induce apoptosis of the secreting cell); long half-life; side effects include injection site rxns, increase susceptibility to infection; may be used alone or in combination with methotrexate
colchicine
used in the treatment of gout for acute attacks or prophylactically; arrests cell division in G1 by interfering with microtubule formation (blocks polymerization), which inhibits neutrophil activation and migration (i.e. inflammation); rapidly absorbed orally, large volume of distribution, has a narrow therapeutic-toxicity window; metabolized by CYP450s and is a substrate for P-glycoprotein; side effects include GI irritation (affects rapidly-proliferating cells); contraindicated in those with hepatic or renal disease, elderly, and pts taking CYP3A4/P-gp inhibitors
etanercept
recombinant fusion protein used in the treatment of RA and juvenile RA; made up of two soluble TNF p75 receptor moieties linked to Fc portion of human IgG; binds soluble TNF-alpha and inhibits its ability to bind its receptor; long half-life; side effects include injection site reactions and increased susceptibility to infection
febuxostat
used in the treatment of gout; non-purine xanthine oxidase inhibitor; more potent than allopurinol, more effective in patients with impaired renal function; similar incidence of most side effects (dizziness, diarrhea, headache, nausea) is similar to allopurinol, but incidence of cardiovascular side effects is higher; inhibits metabolism of azathioprine and mercaptopurine
azathioprine
immunosuppressive drug used in the treatment of RA; inhibits de novo purine synthesis (6-mercaptopurine prodrug, guanine analog)
pegloticase
used in the treatment of gout; pegylated, recombinant form of uricase; converts uric acid to allantoin, an inactive and water-soluble metabolite; side effects include infusion site reactions, gout flare, immune response to PEG; only used in severe cases of gout refractory to other treatment
abatacept
fusion protein used in the treatment of adult RA in pts with inadequate response to one or more DMARD/TNF antagonist; contains endogenous ligand CTLA-4, binds CD80 or CD86 on antigen-presenting cells (prevents activation by CD28); long half-life; side effects include injection site rxn, increased susceptibility to infection
probenecid
uricosuric drug used in the treatment of gout; increases uric acid excretion by competing with renal tubular acid transport to prevent rate reabsorption (OAT/URAT1); side effects include GI irritation, ineffectiveness in pts with renal insufficiency; contraindicated in pts with uric acid kidney stones; interferes with renal excretion of other drugs that undergo active tubular secretion (esp. weak acids)
rituximab
mAb used in the treatment of adult RA in combination with methotrexate in pts with inadequate response to one or more TNF antagonists; anti-CD20, depletes B cells via complement-dependent cytotoxicity and antibody-dependent cytotoxicity; long half-life; side effects include injection site rxns, increased susceptibility to infection
NSAID
used for treatment of gout (w/i 24 hrs of onset of acute attack); also used for RA in large doses for long duration, but does not affect disease progression; also used for osteoarthritis
tocilizumab
mAb used in the treatment of adult RA (pts who have had inadequate response to one or more TNF antagonists); anti-IL-6R, binds both soluble and membrane-bound receptor to inhibit IL-6-mediated signaling via receptors (normally activates T-cells, B-cells, macrophages, and osteoclasts, mediates hepatic acute phase response); long half-life; side effects include injection site rxn, increase susceptibility to infection, alterations in lipid profile (increases cholesterol and triglycerides)
gout
arthritis stemming from a metabolic disorder resulting in elevation of uric acid and inflammatory microcrystals in the joint; more common in women post-menopause; more common in obese individuals; polyarticular gout often affects the PIP and DIP joints; pathology characterized by neutrophils in the synovium/synovial fluid, NSU crystals in cytoplasm of neutrophils
tophaceous gout
repetitive episodes of gout leading to significant tophus deposits on articular surfaces that destroy cartilage; punched-out lesions and overhanging edges of joints visible on X-ray
osteomyelitis
bone infection; sometimes visible on imaging as a region of lucency, but X-rays tend not to be very sensitive (better to use bone scan or MRI); generally does not cause fever; Tx requires long courses of Abx, surgery (removal of sequestra and/or prostheses); bone must be covered by tissue for treatment to be effective
prosthetic joint infection
osteomyelitis resulting from infection of prosthetic material implanted in bone with spread of organisms into adjacent bone; more common in adults; commonly caused by coagulase (-) Staph spp. (like to stick to foreign materials), S. aureus, gram (-), Strep spp.
hematogenous osteomyelitis
bone infection resulting from seeding of bone related to a previous bacteremia; more common in children; may be caused by S. aureus, Strep spp., gram (-), Mycobacterium tuberculosis, Salmonella spp. (in sickle-cell pts)
direct implantation osteomyelitis
bone infection resulting from a penetrating injury; commonly caused by Pseudomonas when precipitated by injury through a shoe, as Pseudomonas likes to grow in damp areas (such as shoes)
contiguous osteomyelitis
bone infection resulting from direct spread of bacteria from an overlying wound or pressure ulcer that is deep with thick exudate; more common in adults; may be related to a diabetic foot ulcer; commonly caused by S. aureus, gram (-), Strep spp., anaerobes, Candida spp.
sequestrum
piece of dead bone resulting from osteomyelitis-related damage to periosteum; may get trapped and behave like a foreign body; requires surgical removal
involucrum
external bone formation as a reaction to osteomyelitis
Brodie’s abscess
bone abscess that develops locally due to osteomyelitis
biofilm
aggregation of microorganisms adherent to a surface, esp. hard surfaces; embedded within a matrix (slime, extracellular polymeric substance, glycocalyx); changes organisms’ biochemistry and physiology (compared to planktonic organisms), more likely to be resistant to Abx